Can ‘Nudge’ Letters Cut Overprescribing of Psych Meds?

“Amol Navathe, MD, PhD, of the Leonard Davis Institute for Health Economics at the University of Pennsylvania in Philadelphia, praised the study. “This is a low-cost, scaleable intervention,” said Navathe, who had co-authored an accompanying JAMA Psychiatry editorial. “I think that is actually really intrinsically important, because we oftentimes have very complicated, expensive interventions, and then we scratch our heads and say ‘Why aren’t they being picked up or scaled?'” Read more at MedPageToday